FDA Approved: SEVELAMER HYDROCHLORIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

The FDA approved a supplemental application for sevelamer hydrochloride (Sanofi) resulting in changes to the product’s labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Drugs mentioned

• Renagel (sevelamer)

Snippet

SUPPL AP for SEVELAMER HYDROCHLORIDE (SEVELAMER HYDROCHLORIDE)